I. Ziółkowska

Association of the heterozygous germline I171V mutation of the NBS1 gene with childhood acute lymphoblastic leukemia

D. Januszkiewicz-Lewandowska, M. Mosor, J. Nowak, 2006, Leukemia.

P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens.

M. Jedryka, A. Płużańska, J. Kupryjańczyk, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen

M. Jedryka, A. Płużańska, J. Kupryjańczyk, 2003, British Journal of Cancer.

Regional distribution of heterozygous 657del5 mutation carriers of theNBS1 gene in Wielkopolska province (Poland)

M. Mosor, J. Nowak, I. Ziółkowska, 2010, Journal of Applied Genetics.

Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene

M. Rydzanicz, M. Wierzbicka, M. Mosor, 2007, Cancer Science.

JAKOŚĆ W MEDYCYNIE Programme to improve hand hygiene in a paediatric cardiac surgery department

R. Jaworski, N. Irga, I. Haponiuk, 2012 .

TP53 status determines clinical significance of ERBB2 expression in ovarian cancer

M. Jedryka, A. Płużańska, J. Kupryjańczyk, 2004, British Journal of Cancer.

Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours.

R. Słomski, A. Pławski, D. Januszkiewicz, 2008, European journal of cancer.

Polymorphisms and haplotypes of the NBS1 gene in childhood acute leukaemia.

D. Januszkiewicz-Lewandowska, M. Mosor, J. Nowak, 2008, European journal of cancer.

Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours.

R. Słomski, A. Pławski, D. Januszkiewicz, 2008, European journal of cancer.